Biogen
BIIB
#1089
Rank
$18.61 B
Marketcap
$127.04
Share price
0.40%
Change (1 day)
-43.29%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

EPS for Biogen (BIIB)

EPS in 2025 (TTM): $10.16

According to Biogen's latest financial reports the company's current EPS (TTM) is $10.16. In 2024 the company made an earnings per share (EPS) of $11.22 an increase over its 2023 EPS that were of $8.03.

EPS history for Biogen from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$10.16-9.45%
2024$11.2239.73%
2023$8.03-61.74%
2022$20.99101.25%
2021$10.43-57.43%
2020$24.50-22.27%
2019$31.5245.66%
2018$21.6481.39%
2017$11.93-29.62%
2016$16.9510.28%
2015$15.3723.65%
2014$12.4357.94%
2013$7.8735.92%
2012$5.7913.53%
2011$5.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
$11.05 8.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$4.78-52.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$2.36-76.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$1.39-86.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$9.07-10.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-$50.31-595.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$2.85-71.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Rad Laboratories
BIO
-$76.17-849.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
-$6.05-159.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
$0.43-95.79%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands